Novo Nordisk
Novo Nordisk raises $500B Public at $550B valuation
Quick Facts
Novo Nordisk: Public Funding Round
Novo Nordisk has successfully raised $500B in Public funding, reaching a valuation of $550B.
Company Overview
Pharmaceutical company
Funding Details
The Public round was led by Public.
Company Information
- Headquarters: Novo Allé, Bagsværd 2880, Denmark
- Founded: 1923
- Employees: 63000+
- Category: Pharmaceuticals
Investment
Novo Nordisk plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public: Verified investor in Public
Key Investors
About the Author
Related Company Reports
Chantal Pharmaceutical Headquarters - Office Location & Address
Discover Chantal Pharmaceutical's headquarters at No 3 Yuanqu St, Taipei, 115. Pharmaceutical manufacturer in Taiwan. Learn about the office facilities and work environment.
Bayer AG Headquarters - Office Location & Address
Discover Bayer AG's headquarters at 51368 Leverkusen, Leverkusen, 51368. Pharmaceutical and life sciences company. Learn about the office facilities and work environment.
Bausch Health Companies Headquarters - Office Location & Address
Discover Bausch Health Companies's headquarters at 2150 St-Elzear Blvd W, Laval, H7L 4A8. Pharmaceutical and medical device company. Learn about the office facilities and work environment.